Evidence map›Paper›PMID 36769164›Full record

ArticleInternational journal of molecular sciences2023

Epigenetic Regulation of Corneal Epithelial Differentiation by TET2.

Yuzuru Sasamoto, Siyuan Wu, Catherine A A Lee, Jason Y Jiang, Bruce R Ksander, Markus H Frank, Natasha Y Frank

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. MYEOV Is a Novel Marker of Differentiated Corneal Epithelium.Investigative ophthalmology & visual science · 2025
    Article
  4. Role of epigenetics in corneal health and disease.Progress in retinal and eye research · 2025
    Review
  5. New perspectives on DNA methylation modifications in ocular diseases.International journal of ophthalmology · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Yuzuru SasamotoDivision of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA.
Siyuan WuDivision of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA.
Catherine A A LeeDivision of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA.ORCID 0000-0001-8525-9342
Jason Y JiangTransplant Research Program, Boston Children's Hospital, Boston, MA 02115, USA.
Bruce R KsanderMassachusetts Eye & Ear Infirmary, Schepens Eye Research Institute, Boston, MA 02114, USA.
Markus H FrankTransplant Research Program, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0000-0002-1312-0488
Natasha Y FrankDivision of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA.
Brigham and Women's Hospital · USBoston Children's Hospital · USEdith Cowan University · AUMassachusetts Eye and Ear Infirmary · US

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Patricia Ann D'Amore · 1985 to 2026
$25.5M
Stem Cell Integral Membrane Transporter ABCB5 and Dermal RegenerationP01AG071463 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Markus H. Frank · 2022 to 2026
$13.6M
ABCB5-positive stem cells for LSCD therapyR01EY025794 · NEI · BOSTON CHILDREN'S HOSPITAL · PI NATASHA Y FRANK, Markus H. Frank · 2016 to 2026
$6.1M
Multipotent ABCB5-positive cell therapeutics for corneal diseaseR24EY028767 · NEI · BRIGHAM AND WOMEN'S HOSPITAL · PI FRANK, MARKUS H., FRANK, NATASHA Y · 2018 to 2022
$5.9M
Organ Design and Engineering Training Program (ODET Program)T32EB016652 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2014 to 2023
$3.5M
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHDR01HL161087 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI FRANK, MARKUS H., FRANK, NATASHA Y · 2022 to 2025
$1.7M
Development of cell-free approaches to the treatment of limbal stem cell deficiencyR00EY031741 · NEI · UNIVERSITY OF WASHINGTON · PI SASAMOTO, YUZURU · 2023 to 2025
$689k
Development of cell-free approaches to the treatment of limbal stem cell deficiencyK99EY031741 · NEI · BRIGHAM AND WOMEN'S HOSPITAL · PI SASAMOTO, YUZURU · 2020 to 2021
$220k
ABCB5+ Dermal Stem Cells In Regenerative Wound HealingI01RX000989 · VA · VA BOSTON HEALTH CARE SYSTEM · PI FRANK, NATASHA Y · 2015 to 2017
–
NEI NIH HHS K99 EY031741NEI NIH HHS P30 EY003790NEI NIH HHS R00 EY031741NEI NIH HHS R01 EY025794NEI NIH HHS R24 EY028767NHLBI NIH HHS R01 HL161087NIA NIH HHS P01 AG071463NIBIB NIH HHS T32 EB016652RRD VA I01 RX000989
6 · The paper itself

Abstract

Epigenetic DNA modification by 5-hydroxymethylcytosine (5hmC), generated by the Ten-eleven translocation (TET) dioxygenases, regulates diverse biological functions in many organ tissues, including the mammalian eye. For example, 5hmC has been shown to be involved in epigenetic regulation of retinal gene expression. However, a functional role of 5hmC in corneal differentiation has not been investigated to date. Here, we examined 5hmC and TET function in the human cornea. We found 5hmC highly expressed in MUC16-positive terminally differentiated cells that also co-expressed the 5hmC-generating enzyme TET2.

Indexed as

DioxygenasesEpigenesis, Genetic5-MethylcytosineCell DifferentiationCorneaDNA-Binding ProteinsDNA MethylationHumansMammalsProto-Oncogene Proteins5-MethylcytosineDioxygenasesDNA-Binding ProteinsProto-Oncogene ProteinsTET2 protein, human5-hydroxymethylcytosine (5hmC)corneal epitheliumdifferentiationgenome-wide 5hmC analysisKRT78MALMYEOVTET2

Identifiers

PMID36769164
PMCPMC9917645
OpenAlexW4319027534

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.